Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.03
Phathom Pharmaceuticals Announces $0 Payment From Eligible Commercially Insured Patients For VOQUEZNA Tablets Through BlinkRx
Benzinga
2026.11.03
Core Molding Technologies Q3 Adj. EPS $0.33 Beats $0.06 Estimate, Sales $90.237M Beat $86.180M Estimate
Benzinga
2026.11.03
IPG Photonics Sees Q4 Adj EPS $0.30-$0.60 vs $0.46 Est; Sees Sales $265.000M-$295.000M vs $290.520M Est
Benzinga
2026.11.03
IPG Photonics Q3 Adj. EPS $0.61 Beats $0.46 Estimate, Sales $287.500M Beat $283.324M Estimate
Benzinga
2026.11.03
Stifel Maintains Hold on BioMarin Pharmaceutical, Lowers Price Target to $66
Benzinga
2026.11.03
Reported November 2, Anthropic Plans To Have 3.5+ GW Of Compute Capacity In 2026 And Double That In 2027; Committed To $807B In Compute And Chip Deals Through 2036 - NY Times
Benzinga
2026.11.03
Ray Dalio Says AI Bubble Is Rising Close To 2000 And 1929 Levels. ‘How Long Do You Let The Bubble Go Before There's The Pricking?’
Benzinga
2026.11.03
Sunoco Q3 EPS $2.07 Beats $1.76 Estimate, Sales $18.029B Beat $13.920B Estimate
Benzinga
2026.11.03
Thomson Reuters Raises 2026 Outlook As AI Gains Momentum
Benzinga
2026.11.03
Coca-Cola Europacific Affirms FY2026 Sales Growth Guidance of 3% to 4% YoY
Benzinga
2026.11.03
Xometry Q3 Adj. EPS $0.28 Beats $0.18 Estimate, Sales $252.430M Beat $235.561M Estimate
Benzinga
2026.11.03
CVR Partners Q3 EPS $(1.02) Down From $4.08 YoY, Sales $146.152M Down From $163.549M YoY
Benzinga
2026.11.03
Piper Sandler Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $215
Benzinga
2026.11.03
Rosenblatt Maintains Buy on Adeia, Lowers Price Target to $35
Benzinga
2026.11.03
Piper Sandler Maintains Neutral on Inspire Medical Systems, Raises Price Target to $70
Benzinga
2026.11.03
Piper Sandler Maintains Overweight on Cactus, Raises Price Target to $78
Benzinga
2026.11.03
Rosenblatt Maintains Buy on Cipher Digital, Lowers Price Target to $19
Benzinga
2026.11.03
Piper Sandler Maintains Overweight on Patterson-UTI Energy, Raises Price Target to $15
Benzinga
2026.11.03
GLJ Research Maintains Buy on Nextpower, Raises Price Target to $158
Benzinga
2026.11.03
Piper Sandler Maintains Overweight on Precision Drilling, Raises Price Target to $115
Benzinga
2026.11.03
Rosenblatt Maintains Neutral on ON Semiconductor, Lowers Price Target to $80
Benzinga
2026.11.03
Piper Sandler Maintains Overweight on Nabors Industries, Raises Price Target to $145
Benzinga
2026.11.03
Peter Brandt Found a Problem With the Silver Shortage Story
BeInCrypto
2026.11.03
Rosenblatt Maintains Buy on Fabrinet, Lowers Price Target to $600
Benzinga
2026.11.03
Piper Sandler Maintains Overweight on TechnipFMC, Raises Price Target to $88
Benzinga
2026.11.03
HC Wainwright & Co. Maintains Buy on Tempus AI, Raises Price Target to $85
Benzinga
2026.11.03
Jim Cramer Likes This Industrial Stock: ‘It’s Come Down A Great Deal’
Benzinga
2026.11.03
These Analysts Revise Their Forecasts On Palantir After Q3 Results
Benzinga
2026.11.03
Needham Reiterates Buy on ON Semiconductor, Maintains $116 Price Target
Benzinga
2026.11.03
Zebra Technologies Narrows FY2026 Adj EPS Guidance from $20.75-$21.25 to $21.20 vs $20.89 Est; Raises FY2026 Sales Guidance from $6.151B-$6.259B to $6.313B vs $6.212B Est
Benzinga
1
...
308
309
310
311
312
313
...
712
>